Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

Status unconfirmed

Conditions studied: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer

In brief

RATIONALE: Studying samples of DNA in the laboratory from women who are BRCA1/BRCA2 mutation carriers may help doctors learn more about cancer and identify biomarkers related to cancer. PURPOSE: This research study is looking at breast cancer risk in women who are BRCA1/BRCA2 mutation carriers.

Key facts

Study ID

NCT00897455

Run by

Gynecologic Oncology Group

People needed

10000

Starts

2008-04-01

Last updated by the study team

2011-03-23

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.